Salarius Pharmaceuticals Stock Price on December 18, 2024
| SLRX Stock | USD 2.69 0.07 2.67% |
If you're considering investing in Salarius Stock, it is important to understand the factors that can impact its price. As of today, the current price of Salarius Pharmaceuticals stands at 2.69, as last reported on the 21st of January, with the highest price reaching 3.30 and the lowest price hitting 2.67 during the day. Salarius Pharmaceuticals is abnormally volatile given 3 months investment horizon. Salarius Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.085, which indicates the firm had a 0.085 % return per unit of risk over the last 3 months. We were able to interpolate data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.57% are justified by taking the suggested risk. Use Salarius Pharmaceuticals Semi Deviation of 6.03, coefficient of variation of 1175.9, and Risk Adjusted Performance of 0.0813 to evaluate company specific risk that cannot be diversified away.
Salarius Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Salarius |
Sharpe Ratio = 0.085
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | SLRX | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 18.5 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.57 actual daily | 31 69% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 6 94% of assets perform better |
Based on monthly moving average Salarius Pharmaceuticals is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Salarius Pharmaceuticals by adding it to a well-diversified portfolio.
Salarius Pharmaceuticals Valuation on December 18, 2024
It is possible to determine the worth of Salarius Pharmaceuticals on a given historical date. On December 18, 2024 Salarius was worth 1.31 at the beginning of the trading date compared to the closed value of 1.22. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Salarius Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Salarius Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Salarius Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Salarius Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 1.41 | 1.41 | 1.30 | 1.33 | 37,085 | |
12/18/2024 | 1.31 | 1.33 | 1.22 | 1.22 | 61,225 |
| 1.22 | 1.62 | 1.22 | 1.41 | 214,338 |
| Backtest Salarius Pharmaceuticals | | | Salarius Pharmaceuticals History | | | Salarius Pharmaceuticals Valuation | Previous | Next |
Salarius Pharmaceuticals Trading Date Momentum on December 18, 2024
| On December 19 2024 Salarius Pharmaceuticals was traded for 1.41 at the closing time. The top price for the day was 1.62 and the lowest listed price was 1.22 . The trading volume for the day was 214.3 K. The trading history from December 19, 2024 was a factor to the next trading day price jump. The trading price change against the next closing price was 15.57% . The trading price change against the current closing price is 30.33% . |
Salarius Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Salarius Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Salarius Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Salarius financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Salarius Pharmaceuticals Stock history
Salarius Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Salarius is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Salarius Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Salarius Pharmaceuticals stock prices may prove useful in developing a viable investing in Salarius Pharmaceuticals
Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing epigenetic-based cancer treatments. It has a strategic partnership with The University of Utah Research Foundation for the exclusive license with respect to patent rights protecting SP-2577 and related compounds HLB Life Sciences to develop, produce, manufacture, use, and sell the drug in South Korea and Cancer Prevention and Research Institute of Texas for product development activities, as well as a research partnership with the Cancer Epigenetics Institute at Fox Chase Cancer Center to identify new indications and biomarkers for SP-2577. Salarius Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 16 people.
Salarius Pharmaceuticals Stock Technical Analysis
Salarius Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Salarius Pharmaceuticals Period Price Range
Low | January 21, 2025
| High |
0.00 | 0.00 |
Salarius Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Salarius Pharmaceuticals January 21, 2025 Market Strength
Market strength indicators help investors to evaluate how Salarius Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Salarius Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Salarius Pharmaceuticals stock market strength indicators, traders can identify Salarius Pharmaceuticals entry and exit signals to maximize returns
Salarius Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Salarius Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Salarius Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Salarius to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0813 | |||
| Jensen Alpha | 1.68 | |||
| Total Risk Alpha | 0.9825 | |||
| Sortino Ratio | 0.223 | |||
| Treynor Ratio | (0.37) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Salarius Stock Analysis
When running Salarius Pharmaceuticals' price analysis, check to measure Salarius Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Salarius Pharmaceuticals is operating at the current time. Most of Salarius Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Salarius Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Salarius Pharmaceuticals' price. Additionally, you may evaluate how the addition of Salarius Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.